GURUFOCUS.COM » STOCK LIST » Industrials » Aerospace & Defense » Medicox Co Ltd (XKRX:054180) » Definitions » EBIT

Medicox Co (XKRX:054180) EBIT : ₩-25,155 Mil (TTM As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Medicox Co EBIT?

Medicox Co's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was ₩-9,079 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-25,155 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Medicox Co's annualized ROC % for the quarter that ended in Dec. 2023 was -13.00%. Medicox Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -73.68%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Medicox Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -76.43%.


Medicox Co EBIT Historical Data

The historical data trend for Medicox Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicox Co EBIT Chart

Medicox Co Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,333.92 -6,734.00 -20,351.19 -39,124.04 -25,155.16

Medicox Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19,133.29 -2,612.39 -8,539.03 -4,924.25 -9,079.49

Competitive Comparison of Medicox Co's EBIT

For the Aerospace & Defense subindustry, Medicox Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicox Co's EV-to-EBIT Distribution in the Aerospace & Defense Industry

For the Aerospace & Defense industry and Industrials sector, Medicox Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medicox Co's EV-to-EBIT falls into.



Medicox Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-25,155 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medicox Co  (XKRX:054180) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Medicox Co's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=-11408.78 * ( 1 - 0% )/( (82846.793 + 92656.492)/ 2 )
=-11408.78/87751.6425
=-13.00 %

where

Invested Capital(Q: Sep. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=91768.21 - 4262.157 - ( 26886.777 - max(0, 34107.972 - 38767.232+26886.777))
=82846.793

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=96690.933 - 4636.552 - ( 17688.952 - max(0, 30638.941 - 30036.83+17688.952))
=92656.492

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Medicox Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-36317.948/( ( (47102.947 + max(-4524.914, 0)) + (51476.39 + max(-5088.921, 0)) )/ 2 )
=-36317.948/( ( 47102.947 + 51476.39 )/ 2 )
=-36317.948/49289.6685
=-73.68 %

where Working Capital is:

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1823.104 + 2318.895 + 5357.017) - (4262.157 + 0 + 9761.773)
=-4524.914

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2194.698 + 1772.093 + 5492.985) - (4636.552 + 0 + 9912.145)
=-5088.921

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Medicox Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=-25155.16/32912.858
=-76.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medicox Co EBIT Related Terms

Thank you for viewing the detailed overview of Medicox Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicox Co (XKRX:054180) Business Description

Traded in Other Exchanges
N/A
Address
40, Nonhyeon-ro 28-gil, 3rd Floor, Deogyeong Building, Gangnam-gu, Seoul, KOR, 137-902
Medicox Co Ltd is specialized in manufacturing curved blocks of large ships. It produces blocks and supplies them to various large shipbuilding companies in Korea.

Medicox Co (XKRX:054180) Headlines

No Headlines